top of page
Mechanisms. Targets. Treatments.
We study how bioactive lipids, neuropeptides, and their receptors contribute to alcohol use disorder, chronic pain, and Parkinson’s disease. By combining preclinical behavioral models, mass spectrometry-based molecular discovery, and GPCR pharmacology, we identify and validate druggable mechanisms with the potential to support new treatments.
Our laboratory offers interdisciplinary training for students and postdoctoral researchers interested in connecting fundamental neuroscience with therapeutic discovery.
bottom of page